Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Kazuhiro Koikawa, Shin Kibe, Futoshi Suizu, Nobufumi Sekino, Nami Kim, Theresa Manz, Benika J. Pinch, Dipikaa Akshinthala, Ana Verma, Giorgio Gaglia, Yutaka Nezu, Shizhong Ke, Chenxi Qiu, Kenoki Ohuchida, Yoshinao Oda, Tae Ho Lee, Babara Wegiel, John G. Clohessy, Nir London, Sandro Santagata, Gerburg M. Wulf, Manuel Hidalgo, Senthil K. Muthuswamy, Masafumi Nakamura, Nathanael S. Gray, Xiao Zhen Zhou, Kun Ping Lu
Topics & Concepts
Tumor microenvironmentCancer researchPIN1BiologyPancreatic cancerGemcitabineCancerCancer cellCancer-Associated FibroblastsImmunotherapyIsomeraseGeneGeneticsTumor cellsBiochemistrySignaling Pathways in DiseaseNeuroblastoma Research and TreatmentsPeptidase Inhibition and Analysis